PROACTIVE Study Evaluation of the Impact of a Multidimensional Geriatric Intervention Program (PROACTIVE)
PROACTIVE Study Evaluation of the Impact of a Multidimensional Geriatric Intervention Program Including a Regular Physical Training, a Medical and Nutritional Follow-up, on Adjuvant Hormonal Treatment Compliance in Breast Cancer Patients Over 70 Years.
PROACTIVE randomized study to evaluate the impact of a multidimensional geriatric intervention on treatment compliance, measured regularly by blood dosing of drug metabolites.
Patients in the intervention group will be proposed:
- A regular geriatric follow up including an attentive screening of joint symptoms and functionality,
- An adapted treatment of join pain,
- Weekly sessions of adapted physical activity (Taï Chi),
- And a systematic correction of vitamin D deficits.
調査の概要
状態
条件
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
-
Lyon、フランス
- Claire Falandry
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Age ≥ 70 years old
- Non metastatic breast cancer, with or without node metastases
- Hormone Receptor (HR) positive breast cancer patients
- Women with breast adenocarcinoma, confirmed by a pathologist and who underwent surgery or radiotherapy
- Introduce an hormonal therapy during 5 years
- Life expectancy > 6 months (at the discretion of the investigator)
- Covered by a Health System where applicable, and/or in compliance with the recommendations of the national laws in force relating to biomedical research
- Patient must be available for follow-up
- Having given written informed consent prior to any procedure related to the study
Exclusion Criteria:
- No other primary malignant tumor < 5-years old except cured in situ cancer of the cervix, in situ urothelial cancer, or basocellular cancer
- Patient with an experimental treatment in the 30 days prior to the enrollment
- Evidence of metastatic disease
- Not under any administrative or legal supervision
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
---|---|
実験的:A: Interventional adapted physical activity + enhanced geriatr
Geriatric (functionality, gait, nutrition) follow-up, biological tests, anti-aromatase agents blood dosing, clinical assessment.
Weekly Taï-Chi exercises.
|
Patients have 3-monthly geriatric follow-up with biological tests, anti-aromatase agents blood dosing and a clinical assessment (M3 to M9, M15 to M22 and M27 to M33). Musculoskeletal adverse events and quality of life level will be reported and analgesic treatment adapted. Patients will be proposed weekly Taï-Chi exercises to improve joint flexibility, muscular tonus and balance and reduce fall risk. A broader geriatric assessment including functionality, gait analysis and nutrition will be performed each year (M12, M24 and M36). |
他の:Arm B: control
Clinical follow-up according to the Guidelines, annual geriatric and nutritional assessment
|
Usual clinical follow-up
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
Compliance of an adjuvant hormonal therapy
時間枠:3 years of follow up
|
Compliance rate is defined as the rate of blood samplings of anti-hormone metabolites in the therapeutic range, within the 7 blood samplings distributed in the 3 years of follow-up
|
3 years of follow up
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
Intensity and duration of musculoskeletal adverse events
時間枠:3 years of follow up
|
Musculoskeletal adverse events will be graded using NCI CTC version 4.0
|
3 years of follow up
|
Activities of daily living, functional walking capacity and changes in balance
時間枠:3 years of follow up
|
3 years of follow up
|
|
Quality of life
時間枠:3 years of follow up
|
Using the Functional Assessment of Cancer Therapy General (FACT-G7) questionnaire
|
3 years of follow up
|
Nutritional status
時間枠:3 years of follow up
|
Using Mini Nutritional Assessment, weight, weight loss, albuminemia
|
3 years of follow up
|
Analgesics consumption
時間枠:3 years of follow up
|
issued from the exhaustive list of documented concomitant medications
|
3 years of follow up
|
協力者と研究者
スポンサー
捜査官
- 主任研究者:Claire Falandry, MD-PhD、Hospices Civils de Lyon
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
乳がんの臨床試験
-
Tianjin Medical University Cancer Institute and...Guangxi Medical University; Sun Yat-sen University; Chinese PLA General Hospital; The First Affiliated... と他の協力者完了
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI); Highlight Therapeutics積極的、募集していない平滑筋肉腫 | 悪性末梢神経鞘腫瘍 | 滑膜肉腫 | 未分化多形肉腫 | 骨の未分化高悪性度多形肉腫 | 粘液線維肉腫 | II期の体幹および四肢の軟部肉腫 AJCC v8 | III期の体幹および四肢の軟部肉腫 AJCC v8 | IIIA 期の体幹および四肢の軟部肉腫 AJCC v8 | IIIB 期の体幹および四肢の軟部肉腫 AJCC v8 | 切除可能な軟部肉腫 | 多形性横紋筋肉腫 | 切除可能な脱分化型脂肪肉腫 | 切除可能な未分化多形肉腫 | 軟部組織線維肉腫 | 紡錘細胞肉腫 | ステージ I 後腹膜肉腫 AJCC (American Joint Committee on Cancer) v8 | 体幹および四肢の I 期軟部肉腫 AJCC v8 | ステージ... およびその他の条件アメリカ